Steve Schonfeld’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$493K Buy
50,350
+37,951
+306% +$375K ﹤0.01% 1823
2026
Q1
$121K Buy
+12,399
New +$114K ﹤0.01% 1853
2025
Q3
Sell
-307,341
Closed -$1.87M 2497
2025
Q2
$1.87M Buy
+307,341
New +$2.31M 0.01% 1025
2024
Q4
Sell
-62,272
Closed -$1.04M 2308
2024
Q3
$1.04M Buy
+62,272
New +$1.34M 0.01% 1146
2023
Q1
Sell
-28,128
Closed -$1.69M 2530
2022
Q4
$1.69M Sell
28,128
-16,662
-37% -$976K 0.01% 893
2022
Q3
$2.72M Buy
+44,790
New +$1.42M 0.02% 744
2022
Q1
Sell
-10,387
Closed -$513K 2855
2021
Q4
$513K Buy
10,387
+6,622
+176% +$367K ﹤0.01% 1242
2021
Q3
$269K Buy
+3,765
New +$234K ﹤0.01% 1588

Other funds holding PRTA

Steve Schonfeld's PRTA Position: Q2 2026 in Review

Steve Schonfeld increased its Prothena Corp (PRTA) stake by 306% in Q2 2026, buying an estimated $375K and bringing the position to 50,350 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Steve Schonfeld first reported a position in PRTA in Q3 2021 and has held it in 8 quarters since. The position peaked at $2.72M in Q3 2022. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Steve Schonfeld held 50,350 shares of Prothena Corp worth $493K as of Q2 2026.
  • Steve Schonfeld bought 37,951 Prothena Corp shares in Q2 2026, an estimated $375K.
  • Prothena Corp made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1823 holding.
  • Steve Schonfeld first reported a position in Prothena Corp in Q3 2021 and has held it in 8 quarters since.
  • Steve Schonfeld's Prothena Corp position peaked at $2.72M in Q3 2022.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.